WE
Wallonie Entreprendre
Activity from announced rounds
Activity in this selectionHealthtech
Wallonie Entreprendre is the public investor identified through its Enodia announcement and Chift and Novadip coverage.
Recorded funding activity
Enodia develops protein-degradation medicines. Chift connects financial software APIs, while Novadip develops regenerative cell therapies. W.IN.G and named regional funds remain distinct from the public investor.
- Rounds participated in
- 0
- Confirmed lead rounds
- — All roles disclosed
- New companies
- 0 First participation on record · 0 follow-on
- Funding in participating rounds
- — 0 disclosed · full round size, not this investor’s share
By stage
No activity in this selection.
By primary sector
No activity in this selection.
By country
No activity in this selection.
Rounds
0 in this selectionNo rounds match this selection.